Dr. Yuan MA, Hong Kong Baptist University, Young Scientist Award | China
Dr. Ma, a graduate of Peking University, has dedicated his career to pushing the boundaries of gene therapy. He has effectively addressed two significant challenges in the field of nucleic acid drugs: short half-life and inadequate affinity. In his proposed research, he takes an innovative approach by focusing on conformational regulation, opening up new avenues for enhancing aptamer affinity. Through in-depth study and comprehension of the interactions between aptamers and target molecules, he has successfully overcome the hurdle of insufficient affinity in drug development. The aptamer-based drugs he has contributed to have garnered orphan drug and pediatric rare disease designations from the US FDA.
gene therapy, nucleic acid drugs, aptamer, orphan drug designation, pediatric rare disease, drug development, half-life, affinity, aptamer-based drugs, US FDA, Peking University, conformational regulation, target molecule interactions, pharmaceutical research, Hong Kong Pharmaceutical Academy, scientific outreach, academic exchange, innovation, drug discovery, molecular interactions.
International Conference on Genetics and Genomics of Diseases
Visit: genetics-conferences.healthcarek.com
Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee
Award registration: genetics-conferences.healthcarek.com/award-registration/
For Enquiries: [email protected]
Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
